Literature DB >> 23342301

(18)F-click labeling of a bombesin antagonist with an alkyne-(18)F-ArBF(3) (-): in vivo PET imaging of tumors expressing the GRP-receptor.

Ying Li1, Zhibo Liu, Curtis W Harwig, Maral Pourghiasian, Joseph Lau, Kuo-Shyan Lin, Paul Schaffer, Francois Benard, David M Perrin.   

Abstract

A clickable alkyne-modified arylborimidine is rapidly converted in 15 minutes to a highly polar (18)F-aryltrifluoroborate anion ((18)F-ArBF(3) (-)) at high specific activity. Following labeling, the alkyne-(18)F-ArBF(3) (-) was conjugated to the peptide bombesin (BBN) within 25 minutes in a second step without need for prior work-up making this one-pot-two-step method easy, user-friendly, and generally applicable. Bombesin was chosen to provide functional PET images of prostate cancer xenografts in mice of which there are few. Whereas BBN is labeled to provide some of the first in vivo tumor images based on this technique, click-labeling is recognized for its generality and broad substrate scope. Hence these results are likely to be useful for click labeling most peptides and other biomolecules.

Entities:  

Keywords:  18F-labeling; PET imaging; bombesin imaging; click chemistry

Year:  2013        PMID: 23342301      PMCID: PMC3545365     

Source DB:  PubMed          Journal:  Am J Nucl Med Mol Imaging


  53 in total

1.  Synthesis and reactivity of a bis-sultone cross-linker for peptide conjugation and [18F]-radiolabelling via unusual "double click" approach.

Authors:  Thomas Priem; Cédric Bouteiller; David Camporese; Anthony Romieu; Pierre-Yves Renard
Journal:  Org Biomol Chem       Date:  2011-12-13       Impact factor: 3.876

Review 2.  Imaging of NETs with PET radiopharmaceuticals.

Authors:  V Ambrosini; P Tomassetti; R Franchi; S Fanti
Journal:  Q J Nucl Med Mol Imaging       Date:  2010-02       Impact factor: 2.346

3.  Novel matrix metalloproteinase inhibitor [18F]marimastat-aryltrifluoroborate as a probe for in vivo positron emission tomography imaging in cancer.

Authors:  Ulrich auf dem Keller; Caroline L Bellac; Ying Li; Yuanmei Lou; Philipp F Lange; Richard Ting; Curtis Harwig; Reinhild Kappelhoff; Shoukat Dedhar; Michael J Adam; Thomas J Ruth; François Bénard; David M Perrin; Christopher M Overall
Journal:  Cancer Res       Date:  2010-08-20       Impact factor: 12.701

4.  18F-labeling of peptides by means of an organosilicon-based fluoride acceptor.

Authors:  Ralf Schirrmacher; Gerrit Bradtmöller; Esther Schirrmacher; Oliver Thews; Julia Tillmanns; Thomas Siessmeier; Hans G Buchholz; Peter Bartenstein; Björn Wängler; Christof M Niemeyer; Klaus Jurkschat
Journal:  Angew Chem Int Ed Engl       Date:  2006-09-11       Impact factor: 15.336

5.  Bombesin analogues for gastrin-releasing peptide receptor imaging.

Authors:  Prasant K Nanda; Usha Pandey; Brienne N Bottenus; Tammy L Rold; Gary L Sieckman; Ashley F Szczodroski; Timothy J Hoffman; Charles J Smith
Journal:  Nucl Med Biol       Date:  2012-01-20       Impact factor: 2.408

6.  MicroPET imaging of breast cancer using radiolabeled bombesin analogs targeting the gastrin-releasing peptide receptor.

Authors:  Jesse J Parry; Rebecca Andrews; Buck E Rogers
Journal:  Breast Cancer Res Treat       Date:  2006-07-13       Impact factor: 4.872

7.  68Ga-labeled inhibitors of prostate-specific membrane antigen (PSMA) for imaging prostate cancer.

Authors:  Sangeeta Ray Banerjee; Mrudula Pullambhatla; Youngjoo Byun; Sridhar Nimmagadda; Gilbert Green; James J Fox; Andrew Horti; Ronnie C Mease; Martin G Pomper
Journal:  J Med Chem       Date:  2010-07-22       Impact factor: 7.446

Review 8.  Gastrin-releasing peptide receptor as a molecular target in experimental anticancer therapy.

Authors:  D B Cornelio; R Roesler; G Schwartsmann
Journal:  Ann Oncol       Date:  2007-03-09       Impact factor: 32.976

Review 9.  The diagnosis and medical management of advanced neuroendocrine tumors.

Authors:  Gregory A Kaltsas; G Michael Besser; Ashley B Grossman
Journal:  Endocr Rev       Date:  2004-06       Impact factor: 19.871

10.  Synthesis, 18F-labeling, and in vitro and in vivo studies of bombesin peptides modified with silicon-based building blocks.

Authors:  Aileen Höhne; Linjing Mu; Michael Honer; P August Schubiger; Simon M Ametamey; Keith Graham; Timo Stellfeld; Sandra Borkowski; Dietmar Berndorff; Ulrich Klar; Ulrike Voigtmann; John E Cyr; Matthias Friebe; Ludger Dinkelborg; Ananth Srinivasan
Journal:  Bioconjug Chem       Date:  2008-08-28       Impact factor: 4.774

View more
  9 in total

1.  One-step (18)F labeling of biomolecules using organotrifluoroborates.

Authors:  Zhibo Liu; Kuo-Shyan Lin; François Bénard; Maral Pourghiasian; Dale O Kiesewetter; David M Perrin; Xiaoyuan Chen
Journal:  Nat Protoc       Date:  2015-08-27       Impact factor: 13.491

Review 2.  18 F-Labeling of Sensitive Biomolecules for Positron Emission Tomography.

Authors:  Hema S Krishnan; Longle Ma; Neil Vasdev; Steven H Liang
Journal:  Chemistry       Date:  2017-09-01       Impact factor: 5.236

3.  Using 5-deoxy-5-[18F]fluororibose to glycosylate peptides for positron emission tomography.

Authors:  Xiang-Guo Li; Kerttuli Helariutta; Anne Roivainen; Sirpa Jalkanen; Juhani Knuuti; Anu J Airaksinen
Journal:  Nat Protoc       Date:  2013-12-19       Impact factor: 13.491

Review 4.  Multimodality imaging of RNA interference.

Authors:  T R Nayak; L K Krasteva; W Cai
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

Review 5.  Fluorescent kinase inhibitors as probes in cancer.

Authors:  Syed Muhammad Usama; Bosheng Zhao; Kevin Burgess
Journal:  Chem Soc Rev       Date:  2021-07-22       Impact factor: 60.615

Review 6.  Fluorine-18 radiochemistry, labeling strategies and synthetic routes.

Authors:  Orit Jacobson; Dale O Kiesewetter; Xiaoyuan Chen
Journal:  Bioconjug Chem       Date:  2014-12-12       Impact factor: 4.774

Review 7.  Reaction of [18F]Fluoride at Heteroatoms and Metals for Imaging of Peptides and Proteins by Positron Emission Tomography.

Authors:  Kymberley R Scroggie; Michael V Perkins; Justin M Chalker
Journal:  Front Chem       Date:  2021-06-23       Impact factor: 5.221

Review 8.  18F-labeling using click cycloadditions.

Authors:  Kathrin Kettenbach; Hanno Schieferstein; Tobias L Ross
Journal:  Biomed Res Int       Date:  2014-05-27       Impact factor: 3.411

9.  Target identification for the diagnosis and intervention of vulnerable atherosclerotic plaques beyond 18F-fluorodeoxyglucose positron emission tomography imaging: promising tracers on the horizon.

Authors:  Jan Bucerius; Ingrid Dijkgraaf; Felix M Mottaghy; Leon J Schurgers
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-10-09       Impact factor: 9.236

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.